Table 2 Top 15 significantly differential expressed lncRNAs between pSS patients and control subjects
up-regulated lncRNA | P value | Fold change | down-regulated lncRNA | P value | Fold change |
|---|---|---|---|---|---|
GABPB1-AS1 | 1.36E-09 | 738.802 | RP11-343H5.4 | 2.17E-14 | − 856.93 |
lnc-AC012652.1.1–1-11 | 1.36E-05 | 289.846 | m121218_154352_00126_c100 | 1.18E-06 | −30.374 |
lnc-TMEM65–4-1 | 1.71E-08 | 51.288 | brain_Pred31224 | 2.85E-08 | −26.599 |
lnc-RBPMS2–3-1_dup1 | 4.34E-04 | 31.393 | lnc-CNOT7–2-1 | 3.41E-04 | −10.070 |
m121212_224522_00126_c100 | 1.15E-08 | 18.981 | lnc-ZNF507–1-1_dup1 | 9.88E-05 | −8.296 |
lnc-YDJC-1-2_dup1 | 3.99E-03 | 8.583 | LINC00847 | 8.57E-03 | −7.030 |
m130128_030356_00126_c100 | 1.81E-03 | 8.125 | m121218_132759_00126_c100 | 2.00E-06 | −6.950 |
NRIR | 2.07E-03 | 7.079 | lnc-MYOM2–7-1_dup1 | 3.69E-04 | −5.980 |
PSMA3-AS1 | 4.37E-04 | 5.963 | m121218_180114_00126_c100 | 3.61E-03 | −5.788 |
lnc-ZNF503-AS2–4-1 | 5.88E-03 | 4.110 | CUFF.400492 | 1.25E-03 | −5.056 |
lnc-C3orf67–3-1_dup1 | 6.69E-03 | 3.961 | lnc-SART3–2-1_dup1 | 2.37E-03 | −4.750 |
lnc-STRBP-9-1 | 8.99E-03 | 3.689 | brain_Pred8666 | 7.42E-03 | −4.069 |
RPL32P1 | 7.02E-04 | 3.567 | SNHG1 | 2.31E-04 | −3.550 |
lnc-RNF150–2-4 | 1.25E-02 | 3.496 | lnc-CLEC4C-1-1_dup1 | 2.86E-03 | −3.498 |
lnc-ERMN-2-1_dup1 | 8.88E-03 | 3.104 | EBLN3 | 6.98E-03 | −3.423 |